Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Andrea Sparwasser"'
Autor:
Kornelis J J van Hateren, Gijs W D Landman, Jarinke F H Arnold, Hanneke Joosten, Klaas H Groenier, Gerjan J Navis, Andrea Sparwasser, Stephan J L Bakker, Henk J G Bilo, Nanne Kleefstra
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0133065 (2015)
Two previous studies concluded that proenkephalin A (PENK-A) had predictive capabilities for stroke severity, recurrent myocardial infarction, heart failure and mortality in patients with stroke and myocardial infarction.This study aimed to investiga
Externí odkaz:
https://doaj.org/article/4690902a24c848bb9ff58f8e8fc22242
Autor:
Allan S. Jaffe, Jeffrey W. Meeusen, Leslie J. Donato, Andrea Sparwaßer, John C. Lieske, Deborah Bergmann
Publikováno v:
Clinical Biochemistry. 58:72-77
Background Endogenous opioids, enkephalins, are known to increase with acute kidney injury. Since the mature pentapeptides are unstable, we evaluated the performance of an assay that measures proenkephalin 119–159 (PENK), a stable peptide formed co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b84da5ea7e15d5a717c4630fbeae5515
https://doi.org/10.1016/j.clinbiochem.2018.05.010
https://doi.org/10.1016/j.clinbiochem.2018.05.010
Autor:
Andrea Sparwaßer, Janine Sachse, Joachim Struck, Sarah Bergmann, Julia Weber, Andreas Bergmann
Publikováno v:
The Journal of Applied Laboratory Medicine. 2:222-233
Background Adrenomedullin (ADM) is a circulating peptide known to regulate vasodilation and vascular integrity. Increased plasma ADM concentrations have been described for several life-threatening conditions, including cardiovascular diseases and sep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a61d994e72d8ac65dad1e9d0a0e2ad7e
https://doi.org/10.1373/jalm.2017.023655
https://doi.org/10.1373/jalm.2017.023655
Autor:
Geralyn Lambert-Messerlian, Miriam Rehfeldt, Andreas Bergmann, Glenn E. Palomaki, Andrea Sparwasser, Barbara O'Brien, Joachim Struck, Josef Köhrle, Elizabeth E. Eklund
Publikováno v:
Pregnancy hypertension. 11
Preeclampsia is a serious complication of pregnancy, threatening fetal and maternal health. The aim of our study is to examine the association between preeclampsia and the connecting peptide of the pregnancy hormone relaxin (pro-RLX2) as a potential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2685f64aa32c9606be79951fbc57ecd5
https://pubmed.ncbi.nlm.nih.gov/29133069
https://pubmed.ncbi.nlm.nih.gov/29133069
Publikováno v:
The journal of applied laboratory medicine. 2(3)
Background The peptide hormone relaxin-2 is implicated in diverse physiological and pathophysiological processes. Several assays are available for quantification of human relaxin-2, but because stability of the mature peptide in serum is limited, mea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::278905be1d6b954f497971e7a4cf031f
https://pubmed.ncbi.nlm.nih.gov/33636845
https://pubmed.ncbi.nlm.nih.gov/33636845
Autor:
Andreas Pfeiffer, Arne Astrup, Baak Marleen A van, M. Osterhoff, Joachim Struck, Olga Pivovarova, Andreas Bergmann, Armand Valsesia, Andrea Sparwasser, Martinez J Alfredo, Natalia Rudovich, Angeliki Papadaki, Dominique Langin, Teodora Handjieva-Darlenska, Nathalie Viguerie, Wim H.M. Saris, Marie Kunesova, Susan A. Jebb, Wolfgang Bernigau, Jorg Hager
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af07b90475656e45c89f803573794f3a
https://doi.org/10.1530/endoabs.41.oc12.3
https://doi.org/10.1530/endoabs.41.oc12.3
Autor:
Natalia, Rudovich, Olga, Pivovarova, Wolfgang, Bernigau, Andrea, Sparwasser, Christopher, Tacke, Veronica, Murahovshi, Gabriele, Mertes, Andreas L, Birkenfeld, Andreas, Bergmann, Martin O, Weickert, Andreas F, Pfeiffer
Publikováno v:
Minerva endocrinologica. 41(4)
Acarbose, an alpha-glucosidase inhibitor, unexpectedly reduced the incidence of hypertension and cardiovascular endpoints in the STOP-NIDDM study. Based on the growing evidence of a link between vasoregulatory peptides and metabolic traits, we hypoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f30e41183720e3854104b40c55e047c7
https://pubmed.ncbi.nlm.nih.gov/27007919
https://pubmed.ncbi.nlm.nih.gov/27007919
Autor:
Andrea Sparwasser, Victoria J. Nikiforova, Nora Klöting, Özlem Gögebakan, Isam Haddad, Anne Cathrin Seltmann, Andreas Pfeiffer, Michael Kruse, Olga Pivovarova, Andreas Bergmann, Natalia Rudovich, Martin O. Weickert, Matthias Blüher
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 97:E731-E739
Natriuretic peptides (NP) regulate cardiovascular homeostasis and have multiple metabolic properties. Decreased levels of NP or "natriuretic handicap" are signs of insulin resistance such as central obesity. Increased expression of NP clearance recep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84cb815fad61d0d023b8ac89b13f21e3
https://doi.org/10.1210/jc.2011-2839
https://doi.org/10.1210/jc.2011-2839
Autor:
Klaas H. Groenier, Andrea Sparwasser, Hanneke Joosten, Jarinke F. H. Arnold, Nanne Kleefstra, Henk J. G. Bilo, Stephan J. L. Bakker, Gijs W. D. Landman, Kornelis J. J. van Hateren, Gerjan Navis
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0133065 (2015)
PLoS ONE, 10(7):e0133065. PUBLIC LIBRARY SCIENCE
PLoS ONE
PLoS ONE, 10(7):e0133065. PUBLIC LIBRARY SCIENCE
PLoS ONE
BackgroundTwo previous studies concluded that proenkephalin A (PENK-A) had predictive capabilities for stroke severity, recurrent myocardial infarction, heart failure and mortality in patients with stroke and myocardial infarction.ObjectivesThis stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6165172d09c3235946ed7c5720a31861
https://research.rug.nl/en/publications/fd4566f8-8a6b-484e-92f4-77408b24da7a
https://research.rug.nl/en/publications/fd4566f8-8a6b-484e-92f4-77408b24da7a
Autor:
Stefan Anker, Andrea Sparwasser, Wolfram Doehner, Olga Pivovarova, Andreas Bergmann, Andreas Pfeiffer, Michael A. Nauck, Özlem Gögebakan, Natalia Rudovich, Ayman M. Arafat
Publikováno v:
Diabetes care. 38(1)
GLP-1 receptor agonists have antihypertensive properties, explained via release of atrial natriuretic peptide (ANP) as shown in mice (1). Whether GLP-1 directly interacts with the natriuretic peptide system in humans was studied in a single report (2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e472e8dac6f45ce75db44570665ed2c3
https://pubmed.ncbi.nlm.nih.gov/25538323
https://pubmed.ncbi.nlm.nih.gov/25538323